Literature DB >> 19774631

Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Roger S Riley1, David Williams, Micaela Ross, Shawn Zhao, Alden Chesney, Bradly D Clark, Jonathan M Ben-Ezra.   

Abstract

Bone marrow examination has become increasingly important for the diagnosis and treatment of hematologic and other illnesses. Morphologic evaluation of the bone marrow aspirate and biopsy has recently been supplemented by increasingly sophisticated ancillary assays, including immunocytochemistry, cytogenetic analysis, flow cytometry, and molecular assays. With our rapidly expanding knowledge of the clinical and biologic diversity of leukemia and other hematologic neoplasms, and an increasing variety of therapeutic options, the bone marrow examination has became more critical for therapeutic monitoring and planning optimal therapy. Sensitive molecular techniques, in vitro drug sensitivity testing, and a number of other special assays are available to provide valuable data to assist these endeavors. Fortunately, improvements in bone marrow aspirate and needle technology has made the procurement of adequate specimens more reliable and efficient, while the use of conscious sedation has improved patient comfort. The procurement of bone marrow specimens was reviewed in the first part of this series. This paper specifically addresses the diagnostic interpretation of bone marrow specimens and the use of ancillary techniques.

Entities:  

Mesh:

Year:  2009        PMID: 19774631      PMCID: PMC6648980          DOI: 10.1002/jcla.20305

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  325 in total

1.  Clinical significance of CD56 expression in patients with acute myeloid leukemia.

Authors:  Je-Jung Lee; Ik-Joo Chung; Duk-Hwan Yang; Sang-Hee Cho; Duck Cho; Dong-Wook Ryang; Hyeoung-Joon Kim
Journal:  Leuk Lymphoma       Date:  2002-09

2.  Full activation of the T cell receptor requires both clustering and conformational changes at CD3.

Authors:  Susana Minguet; Mahima Swamy; Balbino Alarcón; Immanuel F Luescher; Wolfgang W A Schamel
Journal:  Immunity       Date:  2006-12-21       Impact factor: 31.745

3.  Bone marrow cellularity determination: comparison of the biopsy, aspirate, and buffy coat.

Authors:  R A Gruppo; B C Lampkin; S Granger
Journal:  Blood       Date:  1977-01       Impact factor: 22.113

4.  The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage.

Authors:  A Haziot; S Chen; E Ferrero; M G Low; R Silber; S M Goyert
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

5.  Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.

Authors:  Deok-Hwan Yang; Je-Jung Lee; Yeung-Chul Mun; Ho-Jin Shin; Yeo-Kyeoung Kim; Sang-Hee Cho; Ik-Joo Chung; Chu-Myong Seong; Hyeoung-Joon Kim
Journal:  Am J Hematol       Date:  2007-01       Impact factor: 10.047

6.  Activated protein kinase C directly phosphorylates the CD34 antigen on hematopoietic cells.

Authors:  M J Fackler; C I Civin; D R Sutherland; M A Baker; W S May
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

7.  CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes.

Authors:  E Ferrero; C L Hsieh; U Francke; S M Goyert
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

8.  Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.

Authors:  V H J van der Velden; D C H Jacobs; A J M Wijkhuijs; W M Comans-Bitter; M J Willemse; K Hählen; W A Kamps; E R van Wering; J J M van Dongen
Journal:  Leukemia       Date:  2002-08       Impact factor: 11.528

Review 9.  Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex.

Authors:  Mitsuhiro Fujihara; Masashi Muroi; Ken-ichi Tanamoto; Tsuneo Suzuki; Hiroshi Azuma; Hisami Ikeda
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310

10.  CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration.

Authors:  Deborah Glencross; Lesley E Scott; Ilesh V Jani; David Barnett; George Janossy
Journal:  Cytometry       Date:  2002-04-15
View more
  7 in total

Review 1.  Magnetic resonance imaging of the spinal marrow: Basic understanding of the normal marrow pattern and its variant.

Authors:  Mohamed Ragab Nouh; Ahmed Fathi Eid
Journal:  World J Radiol       Date:  2015-12-28

2.  Marrow: red, yellow and bad.

Authors:  Robert Paul Guillerman
Journal:  Pediatr Radiol       Date:  2013-03-12

3.  A BERT model generates diagnostically relevant semantic embeddings from pathology synopses with active learning.

Authors:  Youqing Mu; Hamid R Tizhoosh; Rohollah Moosavi Tayebi; Catherine Ross; Monalisa Sur; Brian Leber; Clinton J V Campbell
Journal:  Commun Med (Lond)       Date:  2021-07-05

4.  A Comparative Study of Bone Marrow Squash and Wedge Aspiration Smears.

Authors:  Neeti Arora Ahluwalia; Naveen Kakkar; Kanwardeep Singh Kwatra
Journal:  Indian J Hematol Blood Transfus       Date:  2020-07-20       Impact factor: 0.900

5.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

6.  MarrowQuant Across Aging and Aplasia: A Digital Pathology Workflow for Quantification of Bone Marrow Compartments in Histological Sections.

Authors:  Josefine Tratwal; David Bekri; Chiheb Boussema; Rita Sarkis; Nicolas Kunz; Tereza Koliqi; Shanti Rojas-Sutterlin; Frédérica Schyrr; Daniel Naveed Tavakol; Vasco Campos; Erica L Scheller; Rossella Sarro; Carmen Bárcena; Bettina Bisig; Valentina Nardi; Laurence de Leval; Olivier Burri; Olaia Naveiras
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-24       Impact factor: 5.555

Review 7.  Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment.

Authors:  Nan Sethakorn; Erika Heninger; Cristina Sánchez-de-Diego; Adeline B Ding; Ravi Chandra Yada; Sheena C Kerr; David Kosoff; David J Beebe; Joshua M Lang
Journal:  Cancers (Basel)       Date:  2022-02-01       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.